WordNet

provide with an index; "index the book"
a numerical scale used to compare variables with one another or with some reference number
the finger next to the thumb (同)index_finger, forefinger
a number or ratio (a value on a scale of measurement) derived from a series of observed facts; can reveal relative changes as a function of time (同)index_number, indicant, indicator
an alphabetical listing of names and topics along with page numbers where they are discussed
adjust through indexation; "The government indexes wages and prices"
list in an index
of or relating to or caused by hormones; "hormonal changes"
the branch of biology that studies the structure and function of cells
the act of classifying and providing an index in order to make items easier to retrieve

PrepTutorEJDIC

(本・雑誌などの)『索引』;図書目録 / 指し示すもの,印 / (計器などの)指針 / 指数・虜 / 《the I-》(カトック教会の)禁所目録 / 〈本など〉‘に'索引をつける / 〈語など〉‘を'索引に載せる
《所有・所属》…『の』,…のものである,…に属する・《材料・要素》…『でできた』,から成る・《部分》…『の』[『中の』] ・《数量・単位・種類を表す名詞に付いて》…の・《原因・動機》…『で』,のために(because of) ・《主格関係》…『の』,による,によって・《目的格関係》…『を』,の・《同格関係》…『という』・《関係・関連》…『についての』[『の』],の点で・《抽象名詞などと共に》…の[性質をもつ] ・《『It is』+『形』+『of』+『名』+『to』 doの形で,ofの後の名詞を意味上の主語として》・《分離》…『から』・《起原・出所》…『から』[『の』](out of) ・《『名』+『of』+『a』(『an』)+『名』の形で》…のような・《『名』+『of』+『mine』(『yours, his』など独立所有格)の形で》…の…・《時》(1)《副詞句を作って》…に《形容詞句を作って》…の・《時刻》《米》…前(to,《米》before)
ホルモンの,ホルモンの影響を受けた
細胞学

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 子宮頚部および膣細胞診：結果の解釈 cervical and vaginal cytology interpretation of results
2. 子宮頸癌スクリーニング検査：子宮頸部細胞診およびヒトパピローマウイルス検査の技術 cervical cancer screening tests techniques for cervical cytology and human papillomavirus testing
3. 子宮頚部細胞診：異型扁平上皮細胞（ASC-USおよびASC-H）の評価 cervical cytology evaluation of atypical squamous cells asc us and asc h
4. 子宮頚部細胞診：高悪性度扁平上皮内病変の評価 cervical cytology evaluation of high grade squamous intraepithelial lesions hsil
5. 子宮頚部細胞診：異型および悪性腺細胞の評価 cervical cytology evaluation of atypical and malignant glandular cells

English Journal

Dyspareunia and lubrication in premature ovarian failure using hormonal therapy and vaginal health.

Pacello PC, Yela DA, Rabelo S, Giraldo PC, Benetti-Pinto CL.AbstractABSTRACT Objective: To evaluate vaginal microbiological and functional aspects in women with and without premature ovarian failure (POF) and the relationship with sexual function. Methods: A cross-sectional study with 36 women with POF under hormonal therapy (HT) was age-matched with 36 women with normal gonadal function. The vaginal trophism was assessed through the hormonal vaginal cytology, vaginal pH and vaginal health index (VHI). Vaginal flora was obtained by the amine test, bacterioscopy and culture for fungi. Sexual function was evaluated through the questionnaire Female Sexual Function Index (FSFI). Results: Women in both groups had similar age and showed similar marital status. The two groups presented vaginal trophic score according to VHI but the trophism was worse among women in the POF. No difference was observed with respect to hormonal cytology and pH. Vaginal flora was similar between groups. Women with POF showed worse sexual performance with more pain and poorer lubrication than women in control group. The VHI, single parameter evaluated with statistical difference between groups, did not correlate with the domains of pain and lubricating in the FSFI. Conclusion: These findings suggest that the use of systemic estrogen among women with POF are not enough to improve complaints of lubrication and pain despite conferring similar trophism and vaginal flora. Other therapeutic options need to be evaluated.
Climacteric : the journal of the International Menopause Society.Climacteric.2013 Nov 5. [Epub ahead of print]
ABSTRACT Objective: To evaluate vaginal microbiological and functional aspects in women with and without premature ovarian failure (POF) and the relationship with sexual function. Methods: A cross-sectional study with 36 women with POF under hormonal therapy (HT) was age-matched with 36 women with n
PMID 24188246

Castration-resistant prostate cancer: AUA Guideline.

Cookson MS, Roth BJ, Dahm P, Engstrom C, Freedland SJ, Hussain M, Lin DW, Lowrance WT, Murad MH, Oh WK, Penson DF, Kibel AS.SourceAmerican Urological Association Education and Research, Inc., Linthicum, Maryland, USA.
The Journal of urology.J Urol.2013 Aug;190(2):429-38. doi: 10.1016/j.juro.2013.05.005. Epub 2013 May 9.
PURPOSE: This Guideline is intended to provide a rational basis for the management of patients with castration-resistant prostate cancer based on currently available published data.MATERIALS AND METHODS: A systematic review and meta-analysis of the published literature was conducted using controlled
PMID 23665272

Identification of a metabolic signature for multidimensional impairment and mortality risk in hospitalized older patients.

Fontana L, Addante F, Copetti M, Paroni G, Fontana A, Sancarlo D, Pellegrini F, Ferrucci L, Pilotto A.SourceDepartment of Medicine, Salerno University Medical School, Salerno, Italy. lfontana@dom.wustl.edu
Aging cell.Aging Cell.2013 Jun;12(3):459-66. doi: 10.1111/acel.12068. Epub 2013 Apr 10.
A combination of several metabolic and hormonal adaptations has been proposed to control aging. Little is known regarding the effects of multiple deregulations of these metabolic and hormonal systems in modulating frailty and mortality in hospitalized elderly patients. We measured 17 biological seru
PMID 23496093